Comparison of benefits and complications of hirudin versus heparin for patients with acute coronary syndromes undergoing early percutaneous coronary intervention.
Roe
M T
MT
Duke Clinical Research Institute, Durham, North Carolina 27715, USA. roe00001@mc.duke.edu
Granger
C B
CB
Puma
J A
JA
Hellkamp
A S
AS
Hochman
J S
JS
Ohman
E M
EM
White
H D
HD
Van de Werf
F
F
Armstrong
P W
PW
Ellis
S G
SG
Califf
R M
RM
Topol
E J
EJ
D000368:Aged; D000789:Angina, Unstable / Q000188:drug therapy* / Q000628:therapy; D015906:Angioplasty, Balloon, Coronary; D006328:Cardiac Catheterization; D005260:Female; D006493:Heparin / Q000009:adverse effects / Q000627:therapeutic use*; D024764:Hirudin Therapy; D006629:Hirudins / Q000009:adverse effects / Q000031:analogs & derivatives*; D006801:Humans; D008297:Male; D008875:Middle Aged; D017202:Myocardial Ischemia / Q000188:drug therapy* / Q000628:therapy; D011994:Recombinant Proteins / Q000009:adverse effects / Q000627:therapeutic use*; D055502:Secondary Prevention; D013577:Syndrome
D006629:Hirudins; D011994:Recombinant Proteins; D006493:Heparin; C060225:desirudin